Dr. Julie Gastier-Foster is the Senior Director of the Institute for Genomic Medicine Clinical Laboratory and Vice Chair of Laboratory Genetics in the Department of Pathology and Laboratory Medicine at Nationwide Children’s Hospital. She is a Professor (Clinical) in the Departments of Pathology and Pediatrics at the Ohio State University College of Medicine. Dr. Gastier-Foster received her PhD in Genetics from Harvard Medical School, and completed her medical genetics training at the Stanford University School of Medicine. She is board-certified in Clinical Cytogenetics and Clinical Molecular Genetics and has nearly 20 years’ experience overseeing CAP/CLIA-certified clinical genetics laboratories. Dr. Gastier-Foster also has significant translational research funding to support the integration of genetic/genomic testing into clinical trials and promote biobanking and tumor processing for new research discoveries. She is responsible for the Children’s Oncology Group (COG) Molecular Reference Laboratories and the COG and SWOG Leukemia Banks. She serves as the Principal Investigator for the COG reference laboratories, providing real time clinical testing for risk-based stratification of COG patients and also works with tumor committees to incorporate new clinical biomarkers. Dr. Gastier-Foster has utilized her biorepository and tumor processing expertise as the Principal Investigator of the National Cancer Institute (NCI) Center for Cancer Genomics Biospecimen Core Resource (BCR) since 2009. The BCR is responsible for tumor pathology review and processing for large scale genomics projects such as The Cancer Genome Atlas (TCGA) and subsequent projects.
Elodie Ghedin, PhD, Professor of Biology and Global Public Health, is a member of the Center for Genomics and Systems Biology at New York University. Her laboratory uses comparative genomics, evolutionary biology, and systems biology techniques to generate critical insight about host-pathogen interactions. Prof. Ghedin studies microbial and viral population structures, and how these impact host response to infection and emerging infectious diseases. Her research has recently focused on characterizing influenza virus diversity within and across infected hosts and the interactions of microbes in the respiratory tract to better understand the dynamics of viral transmission and evolution.
Prof. Ghedin received her BS in Biology and PhD in Molecular Parasitology from McGill University, and a MS in Environmental Sciences from the Université du Québec à Montréal. She was a postdoctorate fellow at the National Institute of Allergy and Infectious Diseases/NIH before joining the Institute for Genomic Research (TIGR; now the J. Craig Venter Institute) where she initiated the Virus Genomics group and led the Influenza Genome Sequencing Project funded by NIAID. She joined the NYU faculty in April 2014, following 8 years at the University of Pittsburgh School of Medicine. In 2011, citing the creativity and collaborative nature of her work, and her contributions to parasitology and virology, Dr. Ghedin was recognized as a fellow by the MacArthur Foundation. In 2012, she was also named a Kavli Frontier of Science Fellow.
Dr. Ginsburg is the founding director for the Center for Applied Genomics & Precision Medicine at the Duke University Medical Center and for MEDx, a partnership between the Schools of Medicine and Engineering to spark and translate innovation. His research addresses the challenges for translating genomic information into medical practice and the integration of precision medicine into healthcare.
He is a member of the Advisory Council to the Director of NIH and is co-chair of the National Academies Roundtable on Genomic and Precision Health and is co-chair of the Global Genomic Medicine Collaborative. He has recently served as a member of the Board of External Experts for the NHLBI, the advisory council for the National Center for Accelerating Translational Science, and the World Economics Forum’s Global Agenda Council on the Future of the Health Sector.
Felix E. Moore, Collegiate Professor of Biostatistics and chair of the Department of Biostatistics, University of Michigan School of Public Health, is a leader in genetic analysis of complex human traits. His team has developed statistical methods, computational algorithms and software that facilitate quick, accurate analysis of genetic studies of human disease. His studies enable a better understanding of human genetic variation and its role in disease biology. Abecasis has made important contributions to understanding conditions as diverse as heart disease, diabetes, psoriasis, macular degeneration. Ongoing projects include the sequencing and analysis of >50,000 deep human genomes – an unprecedented amount of data. Abecasis leads the University’s Biostatistics department, which is training a new generation of scientists and making contributions to the statistical and computational machinery for the analysis of diverse types of biomedical data – including not only genomic data but also electronic health records, registry data and health surveys, a variety of imaging data types, and environmental exposures, among others.
Ido Imit, PhD is a Professor at the Immunology Department at the Weizmann Institute of Science. His lab develops novel single cell genomic and epigenomic methods to characterize the immune system and develop new targets for immunotherapy. Among others, he is a recipient of the 2015 EMBO Gold Medal award for his work to reveal the function of the immune system.
Leif Andersson, PhD is professor at Uppsala University, guest professor at the Swedish University of Agricultural Sciences and visiting professor at Texas A&M University. He has been working on comparative genomics using domestic animals as study objects the last 30 years. The work has focused on domestic animals as models for phenotypic evolution and resulted in a steady stream of interesting findings on genotype-phenotype relationships. In recent years the research program has been expanded to include natural populations such as the Darwin’s finches, ruff and Atlantic herring because of the exciting opportunities opened up by the development of new sequencing technologies.
Daniel De Carvalho, PhD holds the Helen M Cooke Professorship in Cancer Epigenetics, is a Scientist at the Princess Margaret Cancer Centre, and Assistant Professor at the Dept. of Medical Biophysics, University of Toronto. Dr. De Carvalho earned his PhD in Immunology from University of São Paulo in 2009 and did his postdoctoral training in Cancer epigenetics at University of Southern California (USC) at Dr. Peter Jones group from 2010 until 2012. His research focuses on understanding the molecular mechanisms driving epigenetic reprogramming in cancer and on translational aspects of cancer epigenetic therapy. De Carvalho is interested in the potential to use epigenetic therapy to improve immunotherapy in cancer and in using DNA methylation profiling of cell free DNA as a biomarker for cancer early detection and for response to therapy. Nature Medicine highlighted Dr. De Carvalho work as one of the top 10 notable advances in 2015 and by Canadian Cancer Society as one of the Top 10 Research Impact Stories of 2015. Cell, Nature Medicine, New England Journal of Medicine, and the Wall Street Journal wrote editorials about his work, highlighting the potential to improve immunotherapy using epigenetic therapy.
Stirling Churchman, PhD is an Assistant Professor in the Department of Genetics at Harvard Medical School. Using high-resolution quantitative approaches, her laboratory investigates how gene expression is regulated from both the nuclear and mitochondrial genomes. Dr. Churchman majored in physics at Cornell University and obtained her doctorate in physics from Stanford University in 2008. She was a postdoctoral fellow with Jonathan Weissman at University of California, San Francisco. There she developed an approach, native elongation transcript sequencing, NET-seq, that directly visualizes global transcriptional activity through mapping RNA polymerase density genome-wide with single-nucleotide resolution. Dr. Churchman joined the Genetics Department at Harvard Medical School as an Assistant Professor in 2011. She is also an Associate Member of the Broad Institute of Harvard and MIT. Dr. Churchman received the Dale F. Frey Award for Breakthrough Scientists by the Damon Runyon Cancer Research Foundation (2011), a Burroughs Wellcome Fund Career Award at the Scientific Interface (2011-2016) and was named a New Scholar in Aging by the Ellison Medical Foundation (2013-2017).
William Greenleaf, PhD, is an Assistant Professor in the Department of Genetics at Stanford University. He received his AB in Physics from Harvard, his PhD in Applied Physics from Stanford, and carried out postdoctoral research in the Department of Chemistry and Chemical Biology at Harvard. His lab is interested in leveraging new sequencing methods and technologies to understand the physical genome. He is investigating both how the genome is packaged, protected, sequestered, and made accessible within the cell nucleus, as well as how changes in DNA sequence relates changes in structure and function of encoded biological macromolecules.
Nada Jabado, MD, PhD is Professor of the Department of Pediatrics Education/Training at the Research Institute of the McGill University Health Center,. She established her Research Program as a PI in 2003 to study brain tumors, the leading cause of cancer related mortality and morbidity in the pediatric years. She is a clinician-scientist who leads a lab comprised of 6 postdoctoral and clinical fellows, 6 graduate students and 5 research assistants/associates. Her main focus is pediatric and young adult astrocytomas, a deadly group of brain tumors. Her group uncovered that pediatric high-grade astrocytomas (HGA) are molecularly and genetically distinct from adult tumors.They also identified a new molecular mechanism driving pediatric HGA, namely recurrent somatic driver mutations in the tail of histone 3 variants (H3.3 and H3.1). These mutations lead to amino acid substitutions at key residues and are tightly correlated with a distinct global DNA methylation pattern, neuroanatomical locations and age specificities. They aim to identify events affected downstream of each mutation, and validate targets in new models to better advise the use of experimental or pipeline drug(s) or drug combinations that could be rapidly translated into clinical trials. Ultimately, based on their findings, patients could be stratified based on their genetic/molecular signature, and assigned to a beneficial therapeutic strategy, bringing needed effective interventions in this devastating cancer. Additionally, they established a TCGA-like initiative by creating the International CHildhood Astrocytoma INtegrated Genomic and Epigenomic (ICHANGE) Consortium. They say, this is a unique set of resources, which enables the scientific world to investigate astrocytomas in children. It includes databases and access to technology as well as international collaborations from 15 participating countries, including ~1500 annotated glioma tissue samples representative of all grades and ages.
Passionate about research that delivers tangible benefits for farmers, since obtaining a PhD in animal breeding and genetics from the University of New England, Jo’s work has focused on practical tools to illustrate the benefit of better herd-improvement decisions on farm. Jo currently works as a research scientist for Agriculture Victoria on the DairyBio initiative where she uses a multi-disciplinary approach in developing and valuing decision support tools that enable more informed breeding and management decisions on-farm. As a 2018 Endeavour Postdoctoral Fellow, Jo spent 6 months as a visiting scientist Teagasc Moorepark, Ireland.
Jo has a history of active involvement across the wider agricultural sector across numerous not-for-profit organisations, particularly in advocacy and support of young people in agriculture. Jo was awarded a Medal of the Order of Australia (OAM) in 2020 for her service to agriculture through her advocacy and support of young people, volunteering, and contribution to dairy research.
Agricultural Meeting
Leena Tripathi
Dr. Leena Tripathi is the Director of Eastern Africa Hub and Leader of the Biotechnology Program at the International Institute of Tropical Agriculture (IITA). She is leading the transgenic and gene-editing research at IITA. She has been involved in plant biotechnology research for more than 25 years, with specific interests in crop improvement. She focuses on “Science to Practice” and linking scientific innovations to practical applications to solve food production issues worldwide. Her primary research focuses on genetically improving important staple food crops like banana/plantain, cassava, and yam to control diseases and pests. Her scientific contributions have been recognized internationally through several awards and honors, such as excellence awards for outstanding scientist and publications. She has been honored as an Elected Fellow of the American Association for the Advancement of Science (AAAS) for her contributions to Agriculture.
Dr. Tripathi and her team have established a robust genetic transformation platform at IITA-Kenya, to develop transgenic and gene-edited products and transfer these technologies to national agricultural research systems in sub-Saharan Africa. She collaborates globally with advanced labs in the United States, United Kingdom, Europe, and Australia, as well as with national partners in Kenya, Uganda, Ethiopia, Malawi, and Rwanda, and various regional partners. She serves as Editorial Board Member for Plant Biotechnology Journal, Communication Biology, Frontiers in Genome Editing, Scientific Reports, and Plant Cell Reports. Leena obtained her Ph.D. in plant molecular biology and M.Sc. in molecular biology and biotechnology. She worked at the University of North Carolina at Greensboro before joining IITA.
Agricultural Meeting
Anna Sonesson
I work with the design of breeding schemes, including marker-assisted and genomic selection schemes, and with QTL mapping. I also work with the management of genetic variation, i.e. managing inbreeding, both at the level of relationship and at the genomic level. Computer simulation is the basic method used along with analysis of real data. Education: MSc Animal Science, Swedish University of Agricultural Sciences (1996), PhD Animal Breeding and Genetics, Wageningen University (2002).
Agricultural Meeting
Rob Martienssen
Rob Martienssen studies epigenetic mechanisms that shape and regulate the genome, and their impact on transposable elements, first discovered by Barbara McClintock at Cold Spring Harbor Laboratory. These mechanisms underlie clonal propagation of oil palm, with implications for rain forest conservation, and of aquatic plants, including the humble duckweed, that are being engineered in the Martienssen lab for biofuel production and carbon sequestration. The link between epigenetics and RNA interference was named “Breakthrough of the Year” by Science magazine. Dr Martienssen obtained his PhD in Genetics at the Plant Breeding Institute at Cambridge University. After postdoctoral training at the University of California, Berkeley, he joined the faculty at Cold Spring Harbor in 1989. Dr. Martienssen is a Fellow of the Royal Society, and a Howard Hughes Medical Institute Investigator. He was awarded the McClintock Prize in 2018, and the Darwin Medal in 2020. Dr. Martienssen is a co-founder of Orion Genomics LLC and Orion Biosains.
Agricultural Meeting
Lindiwe Sibanda Majele
Prof. Lindiwe Majele Sibanda is a recognized leader, practicing farmer and esteemed policy advisor with a career spanning 30 years. She currently serves as Director and Chair of the African Research Universities Alliance – Centre of Excellence in Sustainable Food Systems (ARUA-SFS) at the University of Pretoria. Prof. Sibanda is also the incoming Research Chair for Sustainable Food Systems at the Future Africa Institute, University of Pretoria. She is also hosted by the University’s Centre of Advancement of Scholarship as a Senior Research Fellow.
Prof. Sibanda is an SDG12.3 Champion on Reducing Food Loss and Waste and is a member of the Leadership Council of the United Nations Sustainable Development Solutions Network (SDSN) – South Africa NationalNetwork. Prof. Sibanda also sits on multiple international boards including Nestlé SA, World Vegetable Centre, the One CGIAR System Board. In previous roles, Prof. Sibanda has served as the Chief Executive Officer and Head of Diplomatic Mission, Food, Agriculture and Natural Resources Policy Analysis Network (FANRPAN) and vice-President at the Alliance for a Green Revolution in Africa (AGRA).
She holds a Ph.D. and MSC in Animal Sciences from the University of Reading, and BSc in Animal Sciences from the University of Alexandria, Egypt.
Agricultural Meeting
Farhad Hormozdiari
Farhad Hormozdiari, a research scientist in the HealthAI team at Google Research, where he combines genetic data and machine learning techniques to improve disease understanding for a diverse set of populations. His long-term research aim includes utilizing genetics and machine learning for better social good. Recently, Farhad has grown his interests and focus in leveraging deep learning and statistical genetics to understand plant genomics and improve crop resistance to climate changes. Prior to Google, Farhad was a postdoctoral fellow at Broad Institute and Harvard T.H. Chan School of Public Health working on multi-omics data to understand the biological mechanisms of human diseases. He obtained his PhD in computer science from UCLA (2016) with focus on fine-mapping of traits and GTEx gene expression. Farhad obtained his M.Sc. in computer science from SFU in Canada and B.S. in computer science from Tehran University in Iran.
Agricultural Meeting
Ben Hayes
Professor Hayes has extensive research experience in genetic improvement of livestock, crop, pasture and aquaculture species, with a focus on integration of genomic information into breeding programs, including leading many large scale projects which have successfully implemented genomic technologies in livestock and cropping industries. Author of more than 250 journal papers, including in Nature Genetics, Nature Reviews Genetics, and Science, contributing to statistical methodology for genomic, microbiome and metagenomic profile predictions, quantitative genetics including knowledge of genetic mechanisms underlying complex traits, and development of bioinformatics pipelines for sequence analysis. Thomson Reuters highly cited researcher in 2015, 2016, 2017 and 2018.
Agricultural Meeting
Gregor Gorjanc
I lead the HighlanderLab, which focuses on managing and improving populations using data science, genetics, and breeding. We focus on populations used for food, feed, and fibre production We are particularly interested in: (i) methods for genetics and breeding, (ii) design and optimisation of breeding programmes, and (iii) analysis of data to unravel biology and to find new ways of improving populations.
Agricultural Meeting
Antonio Augusto Franco Garcia
The ultimate goal of my research projects is trying to have a better understanding of the genetic architecture of quantitative traits, specially (but not exclusively) for polyploids, with emphasis on sugarcane. This could be useful for breeding programs and for geneticists interested on complex traits.
To achieve this goal, I have been investigating statistical genetics methods related to:i) linkage mapping; ii) quantitative trait loci (QTL) mapping; iii) association mapping; iv) genomic selection.
Breeding programs always need to take into consideration important phenomenon such as genotype by environment interaction, and the presence of correlation between traits. My group is also investigating these subjects.
I have a PhD in Genetics and Plant Breeding (Department of Genetics, “Luiz de Queiroz” College of Agriculture, University of São Paulo – ESALQ/USP and a post-doc in Statistical Genetics (Bioinformatics Research Center, North Carolina State University, USA).
I started my career as a researcher working with sugarcane breeding (1995-1998) atFederal University of São Carlos, Araras, SP, Brazil. After, I moved to the Department of Statistics at ESALQ/USP, teaching Calculus, Statistics and Experimental Designs (1998-2002). Nowadays, I am a faculty of Department of Genetics (ESALQ/USP), teaching Genetics, Plant Breeding and Statistical Genetics.
Agricultural Meeting
Mark Cooper
Professor Mark Cooper is Chair of Prediction Based Crop Improvement at The University of Queensland, and a global leader in quantitative genetics and plant breeding. His work involves integrating genomic prediction and crop growth models into an ‘end to end’ framework for crop improvement.
Professor Cooper has pioneered the development of novel genetic modelling methodologies, based on gene networks, to study important properties of quantitative traits in biology, and demonstrated how this new genetic modelling framework can be successfully used in plant breeding to improve prediction of important traits under the influences of selection. Professor Cooper’s work at DuPont Pioneer on drought adaptation in one of the largest maize breeding programs in the world led to the AQUAmax hybrids that presently cover millions of hectares worldwide.
A quantitative geneticist by training, Professor Cooper spent 20 years working with industry in the United States and as CEO of his own consultancy firm Zenrun42, before returning to UQ to build upon the critical mass of predictive agricultural expertise in QAAFI and the wider university.
Agricultural Meeting
Robin Buell
In July 2021, Dr. C. Robin Buell joined the University of Georgia as the Georgia Research Alliance Eminent Scholar Chair in Crop Genomics in the Department of Crop & Soil Sciences and the Center for Applied Genetic Technologies. Prior to joining UGA, she was a University Distinguished Faculty and MSU Foundation Professor of Plant Biology at Michigan State University (2007-2021), an Associate Investigator at The Institute for Genomic Research (1999-2007), and as Assistant Professor at Louisiana State University (1997-1998).
Her research program focuses on the genome biology of plants including comparative genomics, bioinformatics, and computational biology. She has worked on the genomes of Arabidopsis, rice, potato, maize, switchgrass, sweetpotato, mints, and medicinal plants. With expertise in bioinformatics, one component of Dr. Buell’s research is provision of databases and web-based data-mining tools for the greater scientific community. Dr. Buell maintains the Rice Genome Annotation Project, which receives over 2 million page visits a year. Dr. Buell earned her BSc from the University of Maryland, her MSc from Washington State University, and her PhD from Utah State University. Dr. Buell has an active research group composed of postdoctoral research fellows, research assistants, graduate students, undergraduate students and high school interns and collaborates with scientists across the United States and throughout the world. She has served as an editor at Plant Physiology, the Plant Genome, Crop Science, Frontiers in Plant Genetics and Genomics, and Plant Cell. She is a fellow of the American Association for the Advancement for Science and the American Society of Plant Biologists. At UGA, she is a member of the Institute of Plant Breeding, Genetics & Genomics and is the Georgia Research Alliance Eminent Scholar Chair in Crop Genomics.
General Meeting
Beth Shapiro
BethShapiro is an evolutionary biologist who specializes in the genetics of ice age animals and plants. As Professor of Ecology and Evolutionary Biology at UC Santa Cruz and HHMI Investigator, Beth uses DNA recovered from bones and other remains to study how species evolved through time and how human activities affected this dynamic process. Her PhD research developed tools to infer changes in species’ abundance and distribution from chronological samples of genetic data. She has since used these to trace evolutionary changes in organisms ranging from influenza to mammoths, asking questions about domestication, admixture, and pathogen evolution. Her current work develops techniques to recover increasingly trace amounts of DNA such as from environmental and forensic samples. A 2009 MacArthur Fellow, Beth is also an award-winning popular science author and communicator who uses her research as a platform to explore the potential of genomic technologies for conservation and medicine.
General Meeting
Solenne Correard
Live and work on the traditional, ancestral, and unceded territory of the Musqueam, Squamish and Tsleil-Waututh people.
Research associate at the Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Solenne is a molecular biologist and bioinformatician passionate about the complexity of human and non-human genomes, interested in using genomic to help navigate some of today’s worldwide challenges, such as ensuring equal access to personalized medicine to everyone around the globe, regardless of their origin or economic background, and studying climate change repercussions on earth biodiversity and fresh water / food supply to help prevent future dramatic events.
Solenne did her PhD in France studying the dog genome (mostly the non-coding part), followed by a post-doc on the Silent Genomes Project, a project aiming to reduce health care disparities and improve diagnostic success for children with rare genetic diseases from Indigenous populations in Canada. Solenne is now leading the bioinformatic analysis for the Canadian BioGenome Project.
Precision Health Meeting
Judith Mank
Judith Mark uses evolutionary, genomic, and population genetic tools to ask fundamental questions related to how selection acts on males and females within a species, and how the genome responds to contradictory selection to encode sexually dimorphic traits.
Precision Health Meeting
Carolyn Hogg
Carolyn has been working on the conservation of threatened species for over twenty-five years both in Australia and overseas. She is currently the Senior Research Manager for the Australasian Wildlife Genomics Group in the Faculty of Science. She has been working with the Save the Tasmanian Devil Program for the past ten years; in addition to other species such as orange-bellied parrots, koalas, bilbies, and woylies.
Working closely with both her academic and conservation management partners her vision is to create a conservation legacy for Australia by changing the way we integrate science, management, and policy; to proactively promote species’ resilience in the face of a changing world. We are achieving this by developing better tools and technologies to integrate molecular genetics into real-time conservation management decisions.
Precision Health Meeting
Jill Banfield
Jill Banfield is a Professor in the Departments of Earth and Planetary Science and Environmental Science, Policy, and Management (see contact information below). She also has an appointment in the geochemistry group at Lawrence Berkeley National Laboratory. Her primary research interests are in geomicrobiology and environmental microbiology. Her group studies how microorganisms shape, and are shaped by, their natural environments. Her research group studies microbial communities, primarily using cultivation-independent approaches such as genomics (metagenomics) and community proteomics. They work on microbial dissolution and precipitation of minerals, the structure, properties, and reactivity of nanoparticles (many of which are formed by microorganisms), microbial ecology, and microbial evolution. Virtually all of our projects are tied to a field site. Current locations of study are Iron Mountain (northern California), the Angelo Reserve (northern California), the Rifle and East River sites, Colorado, Crystal Geyser, Utah
Precision Health Meeting
Alicia Martin
Alicia R. Martin, Ph.D., is an Instructor in Investigation at the Analytic & Translational Genetics Unit at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and an Associated Scientist at the Broad Institute affiliated with the Stanley Center for Psychiatric Research and the Medical and Population Genetics Program. As a population and statistical geneticist, her research examines the role of human history in shaping global genetic and phenotypic diversity. Given vast Eurocentric study biases, she investigates the generalizability of knowledge gained from large-scale genetic studies across globally diverse populations. She is particularly focused on ensuring that the translation of genetic technologies via polygenic risk does not exacerbate health disparities induced by these study biases. Towards this end, she is also developing statistical methods and resources for multi-ethnic studies and underrepresented populations. She earned her PhD in genetics and MS in biomedical informatics from Stanford University (mentored by Dr. Carlos Bustamante), and received postdoctoral training (mentored by Dr. Mark Daly) at MGH and the Broad Institute.
Precision Health Meeting
Anjené Musick
Dr. Anjené (Anji) Musick is the Director of the Scientific Data Strategy Branch in the Division of Medical and Scientific Research in the National Institutes of Health All of Us Research Program, charged with maximizing the scientific integrity of research data collected on or donated by All of Us participants to achieve the broadest impact for biomedical discovery. She is also the Program Director for the All of Us Genome Centers, overseeing all genomic data production pipelines and workflows for data release in the All of Us Research Hub. She also serves as Chair of the All of Us Regulatory Compliance Committee overseeing the FDA Investigational Device Exemption obtained by All of Us to ethically and responsibly return medically actionable genetic results directly to participants.
Dr. Musick has been at the NIH for over 20 years, starting as a pre-doctoral intramural research fellow at the National Human Genome Research Institute in 1995 where she conducted research on the molecular genetics of type 2 diabetes in Francis Collins’ laboratory. She went on to study genetic epidemiology at the Johns Hopkins Bloomberg School of Public Health, earning her M.P.H. and Ph.D. She then returned to NIH in 2002 as an intramural staff scientist, where she led the genetics research program in the Child Psychiatry Branch in the National Institute of Mental Health (NIMH), primarily focusing on the genetics of childhood onset schizophrenia and other severe neurodevelopmental disorders. In 2012, Dr. Musick transitioned to the extramural program at NIMH, administering the Genetics of Mental Illness and Genetic Epidemiology Programs and served as the Branch Chief of the Genomics Research Branch in the Division of Neuroscience and Basic Behavioral Science.
Precision Health Meeting
Susan Wessler
Susan Wessler is Distinguished Professor of Genetics and the Neil and Rochelle Campbell Chair for Innovation in Science Education at the University of California Riverside. In 2011 she was elected Home Secretary of the U.S. National Academy of Sciences (NAS), the first women to hold this position in its 150-year history. She is a plant molecular geneticist known for her contributions to the field of transposon biology and plant genome evolution. A native of New York City, she received a Ph.D. in biochemistry from Cornell University (1980) and was a postdoctoral fellow at the Carnegie Institution of Washington (1980-1982). She began her career at the University of Georgia in 1983 where she remained until moving to UC Riverside in 2010.
Wessler has contributed extensively to educational and diversity initiatives. As a Howard Hughes Medical Institute Professor (2006), she adapted her research program for the classroom by developing the Dynamic Genome (DG) Course where incoming freshman can experience the excitement of scientific discovery. The DG course is currently taken by over 500 students/year. As NAS Home Secretary, she has spearheaded initiatives that have led to a 40% increase in the number of women elected to membership in the NAS.
She is the recipient of several awards including the Stephen Hales Prize (2011) from the American Society of Plant Biologists, the Excellence in Science Award from FASEB (2012) and the McClintock Prize for Plant Genetics and Genome Studies (2015). She is a member of the National Academy of Sciences (1998), the American Academy of Arts and Sciences (2007), the American Philosophical Society (2013), and a Foreign Member of the Royal Society (2017).
Precision Health Meeting
Dr. Alison Van Eenennaam
Dr. Alison Van Eenennaam is a Cooperative Extension Specialist in the field of Animal Genomics and Biotechnology in the Department of Animal Science at University of California, Davis. She received a Bachelor of Agricultural Science from the University of Melbourne in Australia, and both an MS in Animal Science, and a PhD in Genetics from UC Davis. Her publicly-funded research and outreach program focuses on the use of animal genomics and biotechnology in livestock production systems. Her current research projects include the development of genome editing approaches for cattle. She serves as the bovine genome coordinator for the USDA National Animal Genome Research Program, and is an elected Fellow of the American Association for the Advancement of Science (AAAS). She has given over 700 invited presentations to audiences globally, and uses a variety of media to inform general public audiences about science and technology. She frequently provides a credentialed voice on controversial scientific topics, and has appeared on national media including The Dr Oz Show, NPR, Science Friday, and the Intelligence Squared debate series. She appeared in the 2017 documentary “Food Evolution” narrated by science-communicator Dr. Neil deGrasse Tyson. A passionate advocate of science, Dr. Van Eenennaam was the recipient of the Association of Public and Land-grant Universities (APLU) 2010 National Award for Excellence in Extension, American Society of Animal Science (ASAS) 2014 National Extension Award, the Council for Agricultural Science and Technology (CAST) 2014 Borlaug Communication Award, University of California – Davis 2019 James H. Meyer Distinguished Career Achievement Award, and ASAS 2019 Rockefeller Prentice Award in Animal Breeding and Genetics. Twitter: @BioBeef.
Precision Health Meeting
Nils Stein
Nils Stein, research group leader at Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben, and Professor of Genomics of Plant Genetic Resources at Georg-August University Göttingen, focuses in research on structural and comparative genome analysis of the small grain cereals barley, wheat and rye – with a leading role in genome sequencing of all three species. This work has recently been extended into pan-genome analysis of barley and wheat with the intention of unlocking the genomic diversity of the vast genetic resources available for the small grains hosted in ex situ gene banks. Nils Stein was awarded the Günter and Anna Wricke Award in Applied Genetics and Breeding Research in 2010 for his achievements in Triticeae genome analysis, the IWGSC leadership award in 2017 and the Royal Physiographic Society in Lund, Sweden, Medal in 2021. Between 2015 and 2019 and for a second term since 2020 , next to his main affiliations in Germany, Nils is an adjunct professor at the School of Agriculture and Environment at UWA, Australia.
Precision Health Meeting
Jeffrey Ross-Ibarra
Jeffrey Ross-Ibarra is a professor in the Dept. of Evolution and Ecology at the University of California, Davis. His group works on the evolutionary genetics of maize and its wild relatives the teosintes. Research in his group uses population genetic approaches to address questions ranging from transposable element evolution to the genetics of quantitative traits, maize and human coevolution, domestication, and local adaptation. Work from his group has helped elucidate the genetics mechanisms underlying hybrid vigor in maize, and the role of demography, selection, and introgression in shaping maize evolution.
Precision Health Meeting
Dr. Adam Phillippy
Dr. Adam Phillippy is a Senior Investigator and head of the Genome Informatics Section at the National Human Genome Research Institute (NHGRI). His lab develops efficient computational methods for analyzing DNA sequencing data, including tools for genome assembly, genome alignment, genome clustering, microbial forensics, and metagenomics. He is a co-founder of the Telomere-to-Telomere Consortium and the Vertebrate Genomes Project, which seek to enable the complete and gapless assembly of human and all other vertebrate genomes. In 2019, he was awarded the US Presidential Early Career Award for Scientists and Engineers. His lab’s homepage can be found at https://genomeinformatics.github.io/
Precision Health Meeting
Daniela Lourenco
Daniela Lourenco is an Associate Professor in Animal Breeding, Genetics, and Genomics at the University of Georgia in the United States. She has been working in this field since 2004 and her current interests include the use of genomic information to increase rates of genetic progress, the development of methods for genomic evaluations, and the use of computational algorithms to analyze large data. Her research group has been working on genomic selection in beef and dairy cattle, swine, poultry, and fish. They have been involved in the development and implementation of single-step genomic evaluations for several breeding companies and breed associations. The software and algorithms developed by her group are being used for genomic evaluations around the world.
Precision Health Meeting
Zach Lippman
Zach Lippman is a Professor of Plant Biology at Cold Spring Harbor Laboratory (CSHL) and a Howard Hughes Medical Institute (HHMI) Investigator. His research group integrates genetics, development, genomics, and genome editing to study flowering and flower production in nature and agriculture. Taking advantage of natural and induced variation in these processes in tomato and related Solanaceae plants, Lippman’s group has shown how stem cell proliferation and maturation underlie diversity in vegetative and reproductive shoot systems. Identifying the genes and mechanisms underlying this diversity have led to broader exploration on the roles of structural variation, gene regulation, and epistasis in development, domestication, and breeding. Based on these discoveries, Lippman is developing and applying innovative concepts and tools for crop improvement. His contributions to plant genetics and genome editing were recognized with receiving a MacArthur Fellowship and the US National Academy of Sciences Award in Food and Agriculture.
Precision Health Meeting
Dr. Segenet Kelemu
Dr. Segenet Kelemu, is the Director General & CEO of the International Centre of Insect Physiology and Ecology (icipe) Nairobi, Kenya. She is the fourth Chief Executive Officer, and the first woman to lead icipe. After more than 25 years in the United States of America and Latin America applying cutting-edge science that saw her garner numerous professional and state honours for an exceptional career as a scientist, Dr Kelemu, returned from the diaspora in 2007 to contribute to Africa’s development. Dr. Kelemu is a 2014 L’Oréal-UNESCO Laureate for Women in Science Awards, and one of the top 100 most influential African women featured in the May 2014 Edition of Forbes Africa. Dr. Kelemu was listed among the 10 most influential African women in agriculture by the Journal of Gender, Agriculture and Food Security.
In January 2018, she was recognised by Bill Gates, as one of five ‘Heroes in the Field’ who are using their talents to fight poverty, hunger and disease, and providing opportunities for the next generation. In April 2018, the Women Economic Forum awarded Dr. Kelemu their highest award “Woman of the Decade in Natural and Sustainable Ecosystems” for outstanding leadership. In 2018, she has been featured in The CEO Magazine, Australia, as one of the six exceptional leaders from around the world, breaking ground and shattering the glass ceiling.
She has also received other awards and recognitions including the TWAS Prize for Agricultural Sciences (2011) and an Honorary Doctorate from Tel Aviv University for her professional contributions to society (2015). She is also a recipient of the College of Agriculture Alumni Fellow of Kansas State University, USA (2019; the Science Honoree of the Donald Danforth Plant Science Center in St Louis, Missouri, USA (2019); International Fellow of the Royal Swedish Academy of Agriculture and Forestry (2020); the Ellis Island Medal of Honor, New York (2020); and the 2020 TWAS Regional Award for establishment of vibrant scientific institutions. In 2020, she was recognized and featured by UN Women as one of seven women “Devoted to discovery: seven women scientists who have shaped our world”; and by The International Climate Change Development Initiative as one of “five African women scientists to celebrate.”
She serves in various Boards, advisory panels in major global initiatives and has served in international juries of key science awards. She is a Fellow of various Academies of Sciences. She has been featured in CNN African Voices, the Mind of the Universe, the BBC, the East African, Selamta Magazine (an inflight magazine), Le Monde among others.
Precision Health Meeting
Carol Ibe
Dr. Carol Ibe is a Postdoctoral Scientist working on sustainable wheat production at the John Innes Centre in Norwich, United Kingdom. She obtained a PhD in Plant Sciences from the University of Cambridge where she was a Gates Scholar. Originally from Nigeria, Carol understands the urgent need to develop adequate scientific research capacity to accelerate sustainable food production in African nations. This inspired her to set up the JR Biotek Foundation, a non-profit organisation dedicated to upskilling a new cadre of African scientists who can innovatively apply modern biotechnologies to improve local crops.
Carol has developed several initiatives including the Africa Bio-Venture Creation project, the UK-Africa Food Security Summit, and the Reach & Teach Science in Africa flagship program, which mobilises leading research experts to train early-career agricultural research scientists in African universities and research institutes. Carol has forged and co-led partnerships between the UK, particularly, the world-famous University of Cambridge and research institutions in Nigeria, Ghana, Kenya and Benin Republic with multiple Global Challenges Research Fund (GCRF) awards.
Carol’s outstanding research, leadership and absolute commitment to improving lives and systems has led to several awards including the 2019 Bill Gates Sr. Prize and the University of Cambridge’s Society for the Application of Research Awards (CSAR).
Precision Health Meeting
Joanne Chory
Joanne Chory is a Howard Hughes Medical Investigator, professor and director of the Plant Biology Laboratory, Co-director of the Harnessing Plants Initiative at the Salk Institute for Biological Studies and the Howard H. and Maryam R. Newman Chair in Plant Biology.
Precision Health Meeting
Edward S. Buckler
Edward S. Buckler is a USDA-ARS Research Geneticist and adjunct professor in Plant Breeding and Genetics at Cornell University with an educational background in molecular evolution and archaeology. His group’s research uses genomic, computational, and field approaches to dissect complex traits and accelerate breeding in maize, sorghum, cassava, and a wide range of other crops. With these technologies applied to over 2000 species, now the Buckler group focuses on exploring ways to re-engineer global agricultural production systems to ensure food security, improve nutrition, and respond to climate change. With the USDA-ARS, he leads an informatics and genomics platform to help accelerate breeding for specialty crops and animals. His contributions to quantitative genetics and genomics were recognized with election to the US National Academy of Sciences and as recipient of the inaugural NAS Food and Agriculture Award.
Precision Health Meeting
Julia Bailey-Serres
Julia Bailey-Serres is a plant biologist known for her research on mechanisms of plant adaptive responses to environmental stresses. She is recognized for the in-depth dissection of the function of SUBMERGENCE 1A gene, responsible for survival of rice plants under prolonged submergence as evidenced by its successful use in breeding programs that has led to stabilizing rice grain yield in flood-prone regions of Asia. In addition, she established technologies to uncover the activity of genes in specific cell types of multicellular organisms, through the capture of ribosomes and the associated mRNAs. Bailey-Serres was born and raised in California, graduated from the University of Utah with a BS in biology and the University of Edinburgh with a PhD in botany. She began to work on anaerobiosis and mRNA translation as a postdoctoral researcher at the University of California, Berkeley, an interest she has maintained as a faculty of the University of California, Riverside since 1990. She has mentored 20 postdoctoral researchers and 19 doctoral students and currently directs the Center for Plant Cell Biology. Bailey-Serres is a fellow of the American Association for the Advancement of Science and American Society of Plant Biologists (ASPB). She has served as Secretary for ASPB and as an Associate editor for several journals.
Precision Health Meeting
Pardis Sabeti
Dr. Sabeti’s lab focuses on developing new analytical and genomic methods to study evolutionary adaptation and genetic diversity in humans and pathogens, with three current research foci: (1) Identifying and characterizing the underlying adaptive changes that have shaped the human species over time; and (2) Investigating genetic diversity in pathogens such as Lassa virus, Ebola virus, Zika virus, and Babesia microti, towards improved diagnostics, surveillance, and interventions, and (3) Developing novels tools to detect and diagnose microbes causing human morbidity and mortality.
Precision Health Meeting
Dame Sue Hill
Professor Dame Sue Hill OBE PhD DSC CBiol FRSB Hon FRCP Hon FRCPath is the Chief Scientific Officer for England – providing expert clinical scientific advice across the health system and head of profession for the healthcare science workforce in the NHS and associated bodies – embracing more than 50 separate scientific specialisms.
Sue is the Senior Responsible Officer for Genomics in NHS England, leading developments in this area, having previously established the NHS Genomic Medicine Centres and led the NHS contribution to the 100,000 Genomes Project. She is a respiratory scientist by background with an international academic and clinical research reputation.
Precision Health Meeting
Karen Miga
Karen Miga, assistant professor of biomolecular engineering at UC Santa Cruz, was named one of the 100 most influential people of 2022 by TIME. The honor was announced on May 23.
Miga and her colleagues, Adam Phillippy, Evan Eichler, and Michael Schatz, led an international team of scientists — the Telomere-to-Telomere (T2T) Consortium — to complete the first, gapless sequence of the human genome. Parts of the human genome are now available to study for the first time, allowing researchers to better understand genetic diseases, human diversity, and evolution.
The gaps now filled by the new sequence include the entire short arms of five human chromosomes and cover some of the most complex regions of the genome. These include highly repetitive DNA sequences found in and around important chromosomal structures such as the telomeres at the ends of chromosomes and the centromeres that coordinate the separation of replicated chromosomes during cell division. The new sequence also reveals previously undetected segmental duplications, long stretches of DNA that are duplicated in the genome and are known to play important roles in evolution and disease.
Jennifer Doudna, a biochemist and winner of the 2020 Nobel Prize in Chemistry, wrote of her admiration for Miga and T2T Consortium. “The complete human genome sequence is an invaluable resource that may provide new insights into the origin of diseases and how we can treat them. It also offers the most complete look yet at the genetic script underlying the very nature of who we are as human beings.”
Looking forward, Miga and the T2T Consortium have joined with the Human Pangenome Reference Consortium, which aims to create a new “human pangenome reference” based on the complete genome sequences of 350 individuals.
The standard reference genome (GRCh38) does not represent any one individual but was assembled from multiple donors. Merging them into one linear sequence created artificial structures in the sequence. The Human Pangenome Project will make it possible to compare newly sequenced genomes to multiple complete genomes representing a range of human ancestries.
Miga is joined on TIME’s list of the Top 100 Most Influential People of 2022 by Oprah Winfrey, Volodymyr Zelensky, Ketanji Brown Jackson, Mary J. Blige, Emmett Schelling, and many others. The 2022 TIME100 list is chosen by TIME editors.
Precision Health Meeting
Winston Timp
Winston Timp, an associate professor of biomedical engineering, focuses on the development and application of sequencing technologies to gain a deeper understanding of biology and a more accurate set of clinical tools for human disease. He holds joint appointments in the Department of Molecular Biology and Genetics and the Division of Infectious Diseases at the Johns Hopkins University School of Medicine.
Timp’s research integrates the principles of biophysics, molecular biology and computational biology to create new tools for exploring the epigenomes and genomes of different lifeforms ranging in size from the flu virus to hummingbirds to California redwoods. Based on the knowledge gained from these studies, Timp and his team apply their toolsets to clinical samples for the diagnosis, surveillance, and treatment of human disease.
Recent projects range from using nanopore sequencing to diagnose infectious disease, characterizing the epigenome of colon cancer, reading the transcriptome of the hummingbird, and assembling the genome of the giant sequoia. Timp holds two licensed patents for his work and was awarded a $2 million grant in 2017 and another $3 million grant in 2019 as part of the “Novel Nucleic Acid Sequencing Technology Development” project funded through the National Human Genome Research Institute. He is also part of a Human Frontier Science Program grant on the extreme metabolism of hummingbirds and a National Science Foundation Industry-University Cooperative Research Centers (IUCRC) consortium grant on Chinese hamster ovary (CHO) cell genomics and epigenomics.
Timp is a member of the Biophysical Society, Institute of Electrical and Electronics Engineers, and the American Society of Genetics, and sits on the editorial board for Epigenetic Insights and is a bioRxiv Affiliate. He was part of cross-divisional teams that won Johns Hopkins Discovery Awards in 2017 for a project resolving transcriptome architecture using single molecule direct RNA sequencing, in 2016 for exploring the “essentialome” of the Candida glabrata organism, and in 2015 for a project using sequencing-based transcription factor binding quantification for synthetic biology. He also received a Johns Hopkins Catalyst Award in 2016 for his work in nanopore sequencing.
Timp received bachelor’s degrees in biochemistry, chemistry, physics and electrical engineering from the University of Illinois at Urbana in 2001 and 2002. He then earned his master’s degree and PhD in electrical engineering from the Massachusetts Institute of Technology, where he worked at the Whitehead Institute, focusing his thesis work on the study of cellular communication in a 3-D microenvironment. After receiving his doctorate, Timp trained as a postdoctoral fellow at Johns Hopkins, studying the epigenetics of cancer. He joined the faculty of the Whiting School of Engineering in 2013.
Precision Health Meeting
Freda Miller
Dr. Miller joins UBC from the Hospital for Sick Children in Toronto, where she was a Senior Scientist and Professor at the University of Toronto. She is a Fellow of the Royal Society of Canada and of the American Association for the Advancement of Science and at the Hospital for Sick Children she was a Howard Hughes Medical Institute International Research Scholar and the Canada Research Chair in Developmental Neurobiology. Most recently, Dr. Miller’s accomplishments were recognized by the naming of the “Dr. Freda Miller” public school by the Calgary Board of Education.
Dr. Miller is best known for her work on dermal and neural stem cells and on mechanisms that regulate neuronal survival and growth. Her discovery of dermal stem cells provided insights into the mechanisms underlying skin maintenance and repair and contributed to providing the conceptual basis for using skin as a major source for genesis of human stem cells. At the same time, Dr. Miller discovered new mechanisms determining whether nerve cells live or die, findings that have implications for our understanding of neurodegenerative disorders.
Finally, Dr. Miller has made significant contributions to understanding how stem cells build the brain during normal development and how this goes awry in neurodevelopmental disorders. This led to her recent discovery that the commonly used diabetes drug metformin can recruit endogenous neural precursors and in so doing can promote repair of the injured brain. Together, these discoveries led to clinical trials for therapies that “wake up” our own stem cells to repair the injured brain and skin and to the co-founding of two biotechnology companies.
Precision Health Meeting
Alex Cagan
Alex Cagan investigates evolutionary processes in somatic tissue. His research focuses on characterising mutation and selection in healthy tissues and how this relates to cancer and ageing. Evolution is often considered to be an almost imperceptibly slow process. However, the cells that compose our own bodies are constantly acquiring mutations. Some of these mutations may influence cellular phenotypes, such as growth, resulting in clonal expansions. Over time the body may become a patchwork of clones.
These processes may have profound implications for cancer progression and ageing. Due to technical limitations this evolutionary landscape has remained almost totally unexplored. I work with laser capture microdissection and genome sequencing to describe and understand processes of somatic evolution. I seek to adapt methods from comparative evolutionary genomics to gain new insights into evolution within the body.
Precision Health Meeting
Duncan MacCannell
Duncan MacCannell is the chief science officer for the CDC’s Office of Advanced Molecular Detection (OAMD), where he helps coordinate the implementation and support of pathogen genomics, bioinformatics, high-performance computing and other innovative laboratory technologies across the CDC’s four infectious disease centers. With a broad focus on public health laboratory science and strategic innovation, he manages the agency’s high performance computing center of excellence, and works to integrate standardized, sustainable capacity for advanced laboratory technologies and scientific computing into routine public health practice.
Precision Health Meeting
Benedict Paten
Dr. Benedict Paten is an associate professor in the Department of Biomolecular Engineering at the University of California Santa Cruz (UCSC) and an associate director of the UC Santa Cruz Genomics Institute. He oversees the Computational Genomics Lab and Computational Genomics Platform groups at UCSC, which together are broadly focused on computational genomics, creating algorithms, software, and services addressing biomolecular challenges. He has a Ph.D. from the University of Cambridge and the European Molecular Biology Laboratory in computational biology
Precision Health Meeting
Love Dalen
Love Dalen’s general research interests are focused on the use of DNA technology to investigate the ecology and evolution of different species, and how past environmental changes have determined the distribution and abundance of organisms.
At present, the work we are doing in Stockholm is aimed at investigating how genetic variation, population structure and population size have changed over time, especially in the context of changes in climate during the Late Pleistocene (i.e. the last ice age). We are currently working on several projects on different wild animals, for example lemmings, mammoths, rhinos and cave lions.
Precision Health Meeting
Kaitlin Samocha
Eric Venner is a computational biologist with expertise leading teams of genomic scientists, bioinformaticians and software engineers spanning projects that encompass NGS data analysis, high-throughput genomic variant interpretation, clinical reporting and protein function prediction. He is the Director of Clinical Informatics for the Human Genome Sequencing Center’s Clinical Laboratory at the Baylor College of Medicine, where he is responsible for the architecture, development and maintenance of clinical reporting and bioinformatics pipelines that are in use for multiple genomic medicine projects, including the NIH’s All of Us Research Program and the INSIGHT study in epilepsy and previously for the eMERGE Network, the KidsCanSeq project in collaboration with Texas Children’s Hospital as part of the Clinical Sequencing Evidence-Generating Research (CSER) consortium, the Right10K pharmacogenomics collaboration with the Mayo Clinic, and the HGSC’s HeartCare test. A particular focus is on tools for assessing potential pathogenic genetic variation in a high-throughput manner as well as interoperability with external clinical systems.
Precision Health Meeting
Kaitlin Samocha
Dr. Kaitlin Samocha is an Assistant Professor at Massachusetts General Hospital and an Associated Scientist at the Broad Institute of MIT and Harvard. She is on the steering committee for the Genome Aggregation Database (gnomAD), one of the world’s largest publicly available collections of human genetic variation data. The focus of her research career has been on developing methods and statistical tools to improve the interpretation of genetic variation, particularly rare variation.
She created a mutational model to predict the expected number of newly arising (de novo) variants that have been leveraged to associate dozens of genes with autism spectrum disorders, congenital heart disease, and schizophrenia, among others. As a way to aid variant interpretation, Dr. Samocha developed metrics to measure a gene’s tolerance to mutational changes, including the PLI score that was used to identify thousands of genes intolerant to loss of a single functional copy. Additionally, she led an international consortium studying developmental disorders and identified ~300 significantly associated genes, including 28 that had not been robustly tied to these disorders.
Dr. Samocha received her Ph.D. in Genetics and Genomics in 2016 from Harvard University and trained as a postdoctoral fellow at the Wellcome Sanger Institute.
Precision Health Meeting
Richard Scott
Richard Scott is Chief Medical Officer at Genomics England. He joined the organization in 2015. He is also a Consultant and Honorary Associate Professor in Clinical Genetics at Great Ormond Street Hospital for Children and the UCL Institute of Child Health where his practice focuses on diagnosing children with rare multisystem disorders. Richard trained in medicine at Cambridge University and University College London. He specialized in Paediatrics and subsequently Clinical Genetics in London and completed his Ph.D. in childhood cancer syndromes at the Institute of Cancer Research. Through his clinical practice and in his role at Genomics England he is passionate about harnessing the power of new genomic technologies for the benefit of all patients in mainstream healthcare.
Precision Health Meeting
Niall J Lennon
Niall J Lennon, Ph.D. is the Senior Director of Translational Genomics at the Broad Institute of MIT and Harvard, where he is also an Institute Scientist. He is also the Chief Scientific Officer and Chair of the Board of Managers of CRSP LLC, Broad’s clinical testing laboratory. Dr. Lennon is also an Associate Director of the Gerstner Center for Cancer Diagnostics. He oversees the development, implementation, and validation of disruptive technologies to serve basic research, clinical research, and clinical diagnostics.
Lennon has been with the Broad since 2006, and has contributed to the development of applications for every major massively parallel sequencing platform across a range of fields. In 2013, Lennon built a CLIA/CAP licensed clinical laboratory at the Broad to facilitate return of results to patients and to support clinical trials. More recently, Lennon has led efforts to achieve FDA approval for both large-scale genomics projects (as co-Chair of the regulatory working group for NIH’s All of Us Research Project) and for Broad’s own clinical diagnostic for COVID-19 testing process that has delivered >36 million diagnostic test results to people in the New England region.
Dr Lennon received a Ph.D. in Pharmacology from University College Dublin and completed his Postdoctoral studies at Harvard Medical School and Massachusetts General Hospital. He holds an executive certificate in management from the MIT Sloan School of Management. Lennon is also an Adjunct Professor of Biomedical Engineering at Tufts University.
Precision Health Meeting
Augusto Rendon
Dr. Augusto Rendon leads our 70+ bioinformaticians and data scientists at Genomics England. He has a decade of experience growing and leading bioinformatics teams and overseeing the delivery of bioinformatics and genome analysis for population-scale whole genome sequencing initiatives (specifically, the NIHR Bioresource for Rare Diseases, Genomics England’s 100,000 genomes project, and the whole genome component of England’s Genomic Medicine Service). He also enjoys sharing lessons and experiences with similar international initiatives (including Australia, Canada, Germany, and Denmark).
Augusto is a physicist by background. He did his Ph.D. at the University of Toronto in Medical Biophysics. He then moved to do post-doctoral work in Prof. Willem Ouwehand’s laboratory at the University of Cambridge. There, he used statistical genomics approaches to elucidate the mechanisms of blood formation and platelet function in humans, working with a variety of experimental techniques including functional genomics assays, epigenomics, RNAseq, and DNAseq. A cross between a scientist and an engineer, Augusto divides his time between mentoring his team, infusing bioinformatics and data science across everything that Genomics England does, and spending time with his family.
Precision Health Meeting
Daniel MacArthur
Dr Daniel MacArthur is the Director of the Centre for Population Genomics, based jointly at the Garvan Institute of Medical Research, Sydney and the Murdoch Children’s Research Institute in Melbourne.
Daniel completed his PhD at the University of Sydney before moving to postdoctoral studies at the Wellcome Trust Sanger Institute in Cambridge, UK, and then a faculty position at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and Harvard in Boston. In this position he co-directed the Broad Institute’s Program in Medical and Population Genetics, as well as the NIH-funded Center for Mendelian Genomics, which sequenced the exomes, genomes, and/or transcriptomes of over 10,000 individuals from families affected by severe Mendelian disease. He also led the Genome Aggregation Database (gnomAD) consortium, which produced the world’s largest catalogues of human genetic variation, spanning nearly 200,000 individual exomes and genomes.
Daniel returned to Australia in 2020 to lead the new Centre for Population Genomics, which will focus on developing tools and resources useful for the implementation of population-scale genomic medicine in Australia.
Precision Health Meeting
Stephan Sanders
Dr. Stephan Sanders trained as a pediatric physician in the UK before undertaking a PhD and postdoctoral research position at Yale. He is now an Associate Professor at UCSF in the Department of Psychiatry. His research focuses on using genomics and bioinformatics to understand the etiology of developmental disorders, such as Autism Spectrum Disorder (ASD).
As a member of Dr. Matthew State’s lab, he worked with the Simons Simplex Collection Genomic Consortium (SSCGC) to quantify the role of de novo copy number variants (CNVs) in ASD, including discovering that de novo duplications at 7q11.23 are an ASD risk factor (Sanders et al. Neuron 2011). He also used exome sequencing to show that de novo protein-truncating variants PTVs (also called loss-of-function (LoF) mutations) are associated with ASD. This analysis established a statistical framework for identifying the specific genes involved in ASD pathology, based on these de novo events, discovering that the voltage-gated sodium channel SCN2A is an ASD risk gene (Sanders et al. Nature 2012).
Precision Health Meeting
Keith Yamamoto
As UCSF’s first vice chancellor for Science Policy and Strategy, Keith Yamamoto leads efforts to anticipate the needs of an increasingly dynamic biomedical research endeavor, and to position UCSF optimally, by working within the University as well as influencing and shaping science policy at the state and national levels and beyond.
Throughout his career, Yamamoto has been focused on the practice of science, science education and mentoring, peer review, communication of science, and advocacy for federal support for research. He also directs a basic research lab, making groundbreaking discoveries focused on signaling and transcriptional regulation by nuclear receptors.
Yamamoto has long been a voice for science policy that emphasizes integration at three levels:
basic, clinical and social/behavioral/population research;
a merging of the concepts and approaches of physical sciences, engineering, and computation/math with those of the life sciences; and
effective partnerships between academia, industry, and government.
He believes that such integration will produce transformative scientific advances with the potential to address urgent societal challenges.
After earning his Ph.D. from Princeton University, Yamamoto joined the UCSF faculty in 1976. He has served in several significant leadership roles including chair of the Department of Cellular and Molecular Pharmacology, vice dean for research in the School of Medicine, and vice chancellor for research. He chaired the committee that led the planning of the UCSF Mission Bay campus.
Yamamoto has chaired or served on numerous national committees focusing on a wide range of areas (i.e., public and scientific policy, public understanding and support of biological research, science education, training the biomedical workforce, research funding, and the process of peer review at the NIH). He chairs the Coalition for the Life Sciences and sits on both the National Academy of Medicine Executive Committee and the National Academy of Sciences Division of Earth and Life Studies Advisory Committee. As Chair of the NAS Board on Life Sciences, he created the study committee that produced Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease, the report that enunciated the precision medicine concept, and he has helped lead efforts to implement it at the state and national level as well as at UCSF.
He is an elected member of the National Academy of Sciences, National Academy of Medicine, American Academy of Arts and Sciences, and American Academy of Microbiology, and is a fellow of the American Association for the Advancement of Science.
Precision Health Meeting
Kelly Frazer
Dr. Frazer is an internationally renowned leader in the field of genome biology. She is the director of UC San Diego Institute for Genomic Medicine and is a professor and founding chief of the Division of Genome Information Sciences in the Department of Pediatrics at UC San Diego. Over the past seven years, Dr. Frazer’s lab has systematically derived and characterized a unique collection of iPSC lines from 222 individuals – referred to as iPSCORE (iPSC Collection for Omic Research). The iPSCORE resource is currently being used to conduct genotype – molecular phenotype correlations in both pluripotent stem cells and iPSC-derived cell types.
We have recently completed generating iPSC-derived cardiovascular progenitor cells (CVPCs) from over 135 individuals and are in the process of analyzing how regulatory variants influence the expression of cardiac molecular traits including RNA expression (RNA-seq assays) and chromatin states (ATAC-seq and H3K27ac ChIP-seq assays). We recently established that iPSC-CVPCs are fetal-like, and are leveraging this model system to identify and characterize developmental genetic factors which affect cardiovascular disease later in life by acting in specific fetal cardiac cell types. Overall, our findings provide genetic evidence supporting the fetal origin of cardiovascular disease, provide an analytical framework for identifying fetal acting disease variants by comparing genetic associations across stages of development (i.e. fetal and adult tissues), and show that iPSC-derived tissues can be leveraged to study the function of GWAS variants in relevant cell-types.
Precision Health Meeting
KAREN MIGA
Karen Miga, assistant professor of biomolecular engineering at UC Santa Cruz, was named one of the 100 most influential people of 2022 by TIME. The honor was announced on May 23.
Miga and her colleagues, Adam Phillippy, Evan Eichler, and Michael Schatz, led an international team of scientists — the Telomere-to-Telomere (T2T) Consortium — to complete the first, gapless sequence of the human genome. Parts of the human genome are now available to study for the first time, allowing researchers to better understand genetic diseases, human diversity, and evolution.
The gaps now filled by the new sequence include the entire short arms of five human chromosomes and cover some of the most complex regions of the genome. These include highly repetitive DNA sequences found in and around important chromosomal structures such as the telomeres at the ends of chromosomes and the centromeres that coordinate the separation of replicated chromosomes during cell division. The new sequence also reveals previously undetected segmental duplications, long stretches of DNA that are duplicated in the genome and are known to play important roles in evolution and disease.
Jennifer Doudna, a biochemist and winner of the 2020 Nobel Prize in Chemistry, wrote of her admiration for Miga and T2T Consortium. “The complete human genome sequence is an invaluable resource that may provide new insights into the origin of diseases and how we can treat them. It also offers the most complete look yet at the genetic script underlying the very nature of who we are as human beings.”
Looking forward, Miga and the T2T Consortium have joined with the Human Pangenome Reference Consortium, which aims to create a new “human pangenome reference” based on the complete genome sequences of 350 individuals.
The standard reference genome (GRCh38) does not represent any one individual but was assembled from multiple donors. Merging them into one linear sequence created artificial structures in the sequence. The Human Pangenome Project will make it possible to compare newly sequenced genomes to multiple complete genomes representing a range of human ancestries.
Miga is joined on TIME’s list of the Top 100 Most Influential People of 2022 by Oprah Winfrey, Volodymyr Zelensky, Ketanji Brown Jackson, Mary J. Blige, Emmett Schelling, and many others. The 2022 TIME100 list is chosen by TIME editors.
Precision Health Meeting
Nicola Mulder
Professor Mulder heads the Computational Biology Division at the University of Cape Town (UCT), and is a full member of the Institute of Infectious Disease and Molecular Medicine. She leads H3ABioNet, a large Pan African Bioinformatics Network of 28 institutions in 17 countries, which aims to develop bioinformatics capacity to enable genomic data analysis on the continent. H3ABioNet has developed an extensive training program for African researchers. She also co-leads a Sickle Cell Disease Data Coordinating Centre and a Wellcome Trust Centre Data Integration Platform at UCT and more recently, the DS-I Africa Open Data Science Platform.
She received her PhD in Medical Microbiology from the University of Cape Town and then worked for 8.5 years at the European Bioinformatics Institute in Cambridge, as a Team Leader. At UCT her research focuses on genetic determinants of susceptibility to disease, African genome variation, and microbial genomics and infectious diseases from both the host and pathogen perspectives. Her group provides bioinformatics services and training and develops new algorithms and resources for the analysis of complex African genetic data. Prof Mulder is actively involved in capacity development, including training, education and curriculum development in Bioinformatics. She also sits on a number of international scientific advisory boards.
Precision Health Meeting
Ronald Wapner
Ronald Wapner, MD is a Professor of Obstetrics and Gynecology for Columbia University Irving Medical Center and the Director of Reproductive Genetics. Dr. Wapner is an internationally known physician and researcher specializing in reproductive genetics. He pioneered the development of chorionic villus sampling (CVS) and multi-fetal reduction. He has authored or co-authored over 400 publications and he has been an active investigator in the area of Maternal-Fetal Medicine. He is either a principal or co-investigator for several NICHD-sponsored multi-center studies.
He serves as the center PI for the National Standards for Fetal Growth study and the NuMoM2B study at Columbia University in the Maternal-Fetal Medicine Units Network and recently led a multicenter study evaluating the accuracy, efficacy, and clinical advantages of prenatal diagnosis using microarray analysis. He has recently been granted five-year NIH funding to investigate the costs and benefits of prenatal genetic diagnosis by genomic sequencing. The Society for Maternal-Fetal Medicine has honored Dr. Wapner with both a Lifetime Achievement Award (2015) and The Dru Carlson Memorial Award for Best Research in Ultrasound and Genetics (2017). He has had a significant role in the development of multidisciplinary research studies and clinical research centers throughout his career.
Precision Health Meeting
Dame Sue Hill
Professor Dame Sue Hill OBE PhD DSC CBiol FRSB Hon FRCP Hon FRCPath is the Chief Scientific Officer for England – providing expert clinical scientific advice across the health system and head of profession for the healthcare science workforce in the NHS and associated bodies – embracing more than 50 separate scientific specialisms.
Sue is the Senior Responsible Officer for Genomics in NHS England, leading developments in this area, having previously established the NHS Genomic Medicine Centres and led the NHS contribution to the 100,000 Genomes Project. She is a respiratory scientist by background with an international academic and clinical research reputation.
Precision Health Meeting
Phil Febbo
CHIEF MEDICAL OFFICER
Phil Febbo, MD, was appointed as Chief Medical Officer in March 2018. In this role, he is responsible for developing and executing the Company’s medical strategy to drive genomic testing into healthcare practice. Febbo has a successful track record of translational research, clinical excellence, and for embedding molecular insights into clinical care.
Immediately before joining Illumina, Febbo served as CMO of Genomic Health. Prior to his five years at Genomic Health, Febbo was a Professor of Medicine and Urology at the University of California, San Francisco (UCSF), where his laboratory focused on using genomics to understand the biology and clinical behavior of prostate cancer, and his clinical practice focused on genitourinary oncology.
Before joining the faculty of UCSF as an associate professor in 2010, Febbo worked at Duke University Medical Center’s Institute of Genome Sciences and Policy. He completed his internal medicine residency at the Brigham and Women’s Hospital, and his fellowship in oncology at the Dana-Farber Cancer Institute. After which he was an Attending Physician in the Genitourinary Oncology Center at Dana-Farber, Instructor at Harvard Medical School, and a post-doctoral fellow in Todd Golub’s laboratory at Dana-Farber, as well as the Whitehead Institute Center for Genomic Research of MIT (now the Broad Institute). Throughout his career, Febbo has served as a primary investigator for the Translational Research Program of The Alliance, an NCI-supported cooperative group, where his work focused on incorporating biomarkers into large clinical trials.
Febbo holds a Bachelor of Arts degree in Biology from Dartmouth College and an M.D. from UCSF.
Precision Health Meeting
Stephen B. Montgomery
STANFORD UNIVERSITY
Stephen B. Montgomery is an Associate Professor of Pathology, Genetics and, by courtesy, Computer Science at Stanford University. His laboratory focuses on both functional genomics and bioinformatics approaches to understanding the molecular origins of rare and common genetic diseases. Montgomery has been an active member of multiple large-scale consortia including GREGoR, GTEx and MoTrPAC. His laboratory has developed novel transcriptome-based approaches to identifying impactful rare variants in individuals, families and populations and for measuring gene-by-environment effects.
Precision Health Meeting
Diana W. Bianchi
Diana W. Bianchi is the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and a Senior Investigator in the Center for Precision Health Research at the National Human Genome Research Institute (NHGRI). She received her M.D. from Stanford and her postgraduate training in Pediatrics, Medical Genetics and Neonatal-Perinatal Medicine at Harvard.
Bianchi’s research focuses on noninvasive prenatal screening and development of novel fetal therapies for genetic disorders. She has published over 350 peer-reviewed articles and is one of four authors of Fetology: Diagnosis and Management of the Fetal Patient, which won the Association of American Publishers award for best textbook in clinical medicine in 2000. She has held multiple leadership positions, including Presidents of the International Society for Prenatal Diagnosis (ISPD) and the Perinatal Research Society, council memberships in the Society for Pediatric Research (SPR) and the American Pediatric Society, as a member of the board of directors in the American Society for Human Genetics. She served as the Editor-in-Chief of the journal Prenatal Diagnosis from 2007-2020.
Bianchi has received the Neonatal Landmark Award from the American Academy of Pediatrics, the Maureen Andrew Award for Mentorship from the SPR, the Colonel Harland Sanders Award for lifetime achievement in Medical Genetics, the Pioneer Award from ISPD, and the Health Public Service Visionary Award from the Society for Women’s Health Research. In 2013 she was elected to the National Academy of Medicine. She received an honorary Ph.D. from the University of Amsterdam in 2020.
Precision Health Meeting
Allyson Berent
Allyson Berent is a veterinary internal medicine specialist who serves as the Director of Interventional Endoscopy Services at the largest animal hospital in the world, The Animal Medical Center, in New York City. After graduating from Cornell University College of Veterinary Medicine she completed an internship at the University of Minnesota and a residency in Small Animal Internal Medicine at the Veterinary Hospital of the University of Pennsylvania.
After completing a fellowship in interventional radiology at the Veterinary Hospital of the University of Pennsylvania, a fellowship in Endourology at Thomas Jefferson University, and an Interventional radiology fellowship at the Hospital of the University of Pennsylvania, she served as an Adjunct Assistant Professor in Internal Medicine and Interventional Radiology/ Interventional Endoscopy at the Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania. Berent has a particular focus on medical device development, stem cell therapy through regenerative medicine and selective arterial delivery, ureteral diseases, urinary incontinence and minimally invasive management of upper tract urinary obstructions and biliary obstructions.
In 2014 Berent’s daughter was diagnosed with a rare non-degenerative neurogenetic disorder called Angelman syndrome. In October of 2015 she joined to Board of Directors as a Scientific Director for the Foundation for Angelman Syndrome Therapeutics (FAST), and in March of 2016 became the Chief Science Officer for the Foundation. Berent helped to spearhead the development of a pre-competitive biomarker and outcome measure consortium in order to bring patient focused outcome measures forward for human clinical trials (Angelman Syndrome Biomarker and Outcome Measure Consortium-ABOM) and now serves as the Director of this consortium.
Berent Co-Founded the International Angelman Syndrome Research Council (INSYNC-AS). Through FAST, Berent collaborated with a consortium of scientists to encourage translational research opportunities, in order to help bring novel genetic therapies forward toward human clinical trials. Through this work, with the foundation, Berent co-founded GeneTx Biotherapeutics, a company singularly focused to advance an antisense oligonucleotide (ASO) therapy through IND enabling studies and a phase 1/2 clinical trial. Berent currently serves as the Chief Operating Officer of GeneTx Biotherapeutics, who partnered with Ultragenyx Pharmaceuticals in August of 2019. The Phase 1/2 clinical trial started enrolling patients in February 2020 as the first intrathecally delivered ASO for Angelman syndrome, a study of safety and tolerability of GTX-102.
Precision Health Meeting
Euan Ashley
Born in Scotland, Ashley graduated with 1st class Honors in Physiology and Medicine from the University of Glasgow. He completed medical residency and a PhD at the University of Oxford before moving to Stanford University where he trained in cardiology and advanced heart failure, joining the faculty in 2006. His group is focused on the science of precision medicine. In 2010, he led the team that carried out the first clinical interpretation of a human genome. The article became one of the most cited in clinical medicine that year and was later featured in the Genome Exhibition at the Smithsonian in DC. Over the following 3 years, the team extended the approach to the first whole genome molecular autopsy, to a family of four, and to a case series of patients in primary care. They now routinely apply genome sequencing to the diagnosis of patients at Stanford hospital where Ashley directs the Clinical Genome Program and the Center for Inherited Cardiovascular Disease.
Ashley has a passion for rare genetic disease and was the first co-chair of the steering committee of the Undiagnosed Diseases Network. He was a recipient of the National Innovation Award from the American Heart Association and the NIH Director’s New Innovator Award. He is part of the winning team of the $75m One Brave Idea competition and co-founder of three companies: Personalis Inc ($PSNL), Deepcell Inc, and SVExa Inc. He was recognized by the Obama White House for his contributions to Personalized Medicine and in 2018 was awarded the American Heart Association Medal of Honor for Genomic and Precision Medicine. He was appointed Stanford Associate Dean in 2019. In 2021, his first book The Genome Odyssey – Medical Mysteries and the Incredible Quest to Solve Them was released. Father to three young Americans, in his ‘spare’ time, he tries to understand American football, plays jazz saxophone, and conducts research on the health benefits of single malt Scotch whisky.
Precision Health Meeting
Sharon F. Terry
Sharon F. Terry is President and CEO of Genetic Alliance, an enterprise engaging individuals, families and communities to transform health.Genetic Alliance works to provide programs, products, and tools for ordinary people to take charge of their health and to further biomedical research.
As ‘just a Mom’ with a master’s degree in theology, she cofounded PXE International, a research advocacy organization for the genetic condition pseudoxanthoma elasticum (PXE), in response to the diagnosis of PXE in her two children in 1994.She is a co-discoverer of the ABCC6 gene, and patented it to ensure ethical stewardship in 2000, assigning her rights to the foundation.She subsequently developed a diagnostic test and conducts clinical trials.She is the author of 150 peer-reviewed papers, of which 30 are clinical PXE studies. Her story is the topic of her TED Talk and TED Radio Hour.
In her focus at the forefront of consumer participation in genetic research, services and policy, she serves in a leadership role on many of the major international and national organizations, including the Precision Medicine Initiative Cohort Advisory Panel; Accelerating Medicines Partnership; National Academy of Medicine Roundtable on Genomics and Precision Health; the PhenX scientific advisory board; the Global Alliance for Genomics and Health; the International Rare Disease Research Consortium Executive Committee; Genome Medical; LunaDNA; and as Founding President of EspeRare Foundation of Geneva, Switzerland. Terry is co-founder of the Genetic Alliance Registry and Biobank.She is the chair of the National Academy of Medicine Health Sciences Policy Board. She is on the editorial boards of several journals, including Genome, Patient Engagement Editor for Genetic Alliance’s official journal Genetic Testing and Molecular Biomarkers, Chief Patient Advisor for Clinical and Translational Science. She led the coalition that was instrumental in the passage of the Genetic Information Nondiscrimination Act.She received an honorary doctorate from Iona College for her community engagement work in 2006; the 2011 Research!America Distinguished Organization Advocacy Award and an inaugural member of Disruptive Women in Health Care in 2009; and the Clinical Research Forum and Foundation’s Annual Award for Leadership in Public Advocacy in 2011. She was named one of FDA’s “30 Heroes for the Thirtieth Anniversary of the Orphan Drug Act” in 2013. She is co-inventor of the Platform for Engaging Everyone Responsibly (PEER), receiving a large grant from the Robert Wood Johnson Foundation in 2014.She was Co-PI of the PCORnet Coordinating Center and Chair of the PCORnet Engagement Committee. She was a member of the Blue Ribbon Panel’s Working Group on Enhanced Data Sharing for the Cancer Moonshot. She was named a National Associate of the National Research Council, National Academies of Engineering, Sciences, and Medicine for her extraordinary service. She received the Health 2.0 Health Activist award in 2016. In 2017, she co-founded the People Centered Research Foundation. In 2019, she won the Luminary Award from the Precision Medicine World Conference. In 2021, she was awarded the American Society of Human Genetics Advocacy Award.
Terry is an Ashoka Fellow.She is an avid student and facilitator of Gestalt Awareness Practice, offering workshops and individual facilitation. Her daughter and son are why she started down this path. They, their wives, and her granddaughter ground and enliven her.
Hamish S. Scott, BSc (Hons), PhD, FFSc (RCPA), FAHMS, has transformed his department from being largely diagnostic (40 people) to being a dynamic academic/diagnostic department integrated with basic and clinical research. His department has 35 full-time research personnel and is active in student (science and medical) placements, training (PhDs, registrars, overseas post-docs) and clinical trials. His passion is linking research to diagnostics and clinical translation. He has been imbedded within diagnostic units for all but 8 of his 35 year laboratory career.
He has helped develop and introduce new technologies for both somatic and germline genotyping for improved diagnoses and treatment of cancers and genetic diseases including national and international firsts, for which his team has won several prizes. He has substantive experience of functional studies, modelling diseases, in vitro, ex vivo and in vivo using molecular, cellular and mice models. He is on the National Steering Committee (NSC) and SA leader of Australian Genomics (Health Alliance). He is the co-leader of national and international projects such as national Australian study to identify genetic causes of perinatal death.
Precision Health Meeting
Gretchen Bandoli
I am an Assistant Professor in the Department of Pediatrics at UC San Diego. My research interests include pregnancy and early childhood determinants of health. I also am interested in the expansion of methodology to characterize complex exposures across gestation, including substances (alcohol, marijuana) and medications. I am a co-investigator of the Study of Mothers and Infants, a large administrative database linked to biospecimens allowing us to study genetic and environmental contributors to pregnancy and child outcomes.
Registration opens mid-September. Join our newsletter, and be among the first to sign up for this premier event!
We are no longer accepting nominations for 2020 speakers, but check back in 2021!
Applications and call for abstracts will open mid-September.